已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Systemic Chemotherapy with or without Hepatic Arterial Infusion Chemotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Oligometastasis: A Propensity Score–Matched Analysis

医学 倾向得分匹配 内科学 化疗 胃肠病学 肝内胆管癌 肿瘤科 放射科
作者
Zhenfeng Li,Ran Xu,Chang Xu,Peng Sun
出处
期刊:Journal of Vascular and Interventional Radiology [Elsevier BV]
卷期号:35 (3): 416-427.e17 被引量:2
标识
DOI:10.1016/j.jvir.2023.11.015
摘要

Abstract

Purpose

To compare the effectiveness of hepatic arterial infusion chemotherapy (HAIC) plus systemic chemotherapy (SYS) with that of SYS alone in patients with intrahepatic cholangiocarcinoma (ICC) with extrahepatic oligometastasis in terms of overall survival (OS) and mortality related to liver failure.

Materials and Methods

Consecutive patients diagnosed with ICC with extrahepatic oligometastasis who received either HAIC plus SYS or SYS alone between January 2019 and January 2021 were included in this retrospective cohort study. Propensity score matching (PSM) analysis was performed to address potential confounding factors. OS, progression-free survival (PFS), and intrahepatic progression–free survival (IPFS) were analyzed. The occurrence of death due to liver failure was also assessed.

Results

The study included a total of 179 patients, with 96 receiving SYS alone and 83 receiving HAIC plus SYS. After PSM, 83 pairs were included for further analysis. The median OS and IPFS were significantly longer in the HAIC plus SYS group compared to the SYS alone group (OS: 15.8 months vs 12.7 months; P = .023; IPFS: 9.7 vs 6.1 months; P < .001). No difference was found in PFS between the 2 groups. The HAIC plus SYS group had a significantly lower rate of mortality due to liver failure compared to the SYS alone group (42% vs 72%; P = .002).

Conclusions

HAIC plus SYS is a promising treatment approach for patients with ICC and extrahepatic oligometastasis with improved OS, IPFS, and freedom from liver failure mortality compared with SYS alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
七慕凉应助寒冰寒冰采纳,获得10
1秒前
星辰大海应助刘江涛采纳,获得10
1秒前
半圭为璋发布了新的文献求助10
2秒前
高天雨完成签到 ,获得积分10
3秒前
cclyfan完成签到,获得积分10
4秒前
4秒前
研友_VZG7GZ应助dkm采纳,获得10
4秒前
华桦子完成签到 ,获得积分10
5秒前
王王完成签到 ,获得积分10
5秒前
坦率尔琴完成签到,获得积分10
5秒前
bkagyin应助芯之痕采纳,获得10
6秒前
深情安青应助鱼子酱采纳,获得10
7秒前
wangfang0228完成签到 ,获得积分10
7秒前
7秒前
Mandy完成签到 ,获得积分10
8秒前
8秒前
幸福的鑫鹏完成签到,获得积分10
8秒前
9秒前
10秒前
11秒前
Ther完成签到 ,获得积分10
11秒前
丘比特应助xiaoxiao_121采纳,获得10
12秒前
12秒前
沉默完成签到,获得积分10
13秒前
WangJL完成签到 ,获得积分10
13秒前
junkook完成签到 ,获得积分10
13秒前
大渡河完成签到,获得积分10
13秒前
魏芸芸完成签到,获得积分10
14秒前
fdwonder完成签到,获得积分10
15秒前
FYhan完成签到 ,获得积分10
15秒前
去小岛上流浪完成签到,获得积分10
15秒前
shentaii完成签到,获得积分10
16秒前
wcy完成签到 ,获得积分10
16秒前
17秒前
17秒前
闪闪璎发布了新的文献求助10
17秒前
kai chen完成签到 ,获得积分0
17秒前
田鹤飞完成签到,获得积分10
18秒前
sci完成签到 ,获得积分10
20秒前
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976560
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204287
捐赠科研通 3257271
什么是DOI,文献DOI怎么找? 1798653
邀请新用户注册赠送积分活动 877835
科研通“疑难数据库(出版商)”最低求助积分说明 806570